DR. REDDY’S LABORATORIES LIMITED (RDY)

Every figure this model derived for RDY, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 322,000,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-03-31
cash 172,000,000 CashAndCashEquivalents 2025-03-31
current assets 2,928,000,000 CurrentAssets 2025-03-31
current liabilities 1,527,000,000 CurrentLiabilities 2025-03-31
equity 3,903,000,000 EquityAttributableToOwnersOfParent 2025-03-31
interest expense 33,000,000 FinanceCosts 2025-03-31
ocf 545,000,000 CashFlowsFromUsedInOperatingActivities 2025-03-31
revenue 3,811,000,000 Revenue 2025-03-31
sbc 5,000,000 AdjustmentsForSharebasedPayments 2025-03-31

The ratios

The figures themselves rather than their scores — what somebody looking up RDY on one particular measure came for.

RatioValue
cash operating margin27.47
current ratio1.92
current ratio reported1.92
dilution pct0.08
ebit cagr26.2
ebit yoy3.57
fcf margin5.85
growth cv0.27
interest cover25.52
net debt ebitda0.35
operating margin22.09
owner earnings margin5.72
revenue growth13.76
revenue growth per share13.67
roic15.59
rule of 4035.86
sbc pct revenue0.13

What to be careful about

What this model itself distrusts about RDY's figures. Written by the derivation as it ran, not added afterwards.